- STOCKWATCH: The 'X' factory – multiple reasons to be fearful
- US Capitol Capsule: What's life & limb worth? Gauging antibiotics' value
- STOCKWATCH: EU conditional approvals – what gives?
- BioNotebook: Big bets in life science venture capital; Chimerix stock offering; IPOs and dealmaking abound
COMMENT Other Informa Comment